⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for endometrioid endometrial cancer

Every month we try and update this database with for endometrioid endometrial cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic MalignanciesNCT05705505
Endometrioid En...
Narazaciclib
Letrozole 2.5mg
18 Years - Traws Pharma, Inc.
P16 Staining as Prognostic Biomarker in Serous Papillary Endometrial CancerNCT01267357
Serous Papillar...
no intervention
18 Years - Rambam Health Care Campus
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial CancerNCT05997017
Endometrial Can...
Endometrioid Tu...
Cancer
Tumor
Recurrent Endom...
Endometrioid En...
nab-sirolimus
18 Years - Aadi Bioscience, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: